Management of epidermolysis bullosa

Bibliography

• Fine J-D, Hintner H. Life with epidermolysis bullosa: etiology, diagnosis, and multidisciplinary care and therapy. Springer Verlag GmbH, Wien New York; 2009
   Google Scholar
• Fine JD, Mellerio J. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs. J Am Acad Dermatol 2009;61:387-402
   Google Scholar
• Fine JD, Mellerio J. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol 2009;61:367-84
   PubMedGoogle Scholar
• Fine J-D, Johnson LB, Weiner M, Suchindran C. Cause-specific risks of childhood death in inherited epidermolysis bullosa. J Pediatr 2008;152:276-80
   PubMed Web of Science ®Google Scholar
• Fine J-D, Johnson LB, Weiner M, Suchindran C. Gastrointestinal complications of inherited epidermolysis bullosa: cumulative experience of the National EB Registry. J Pediatr Gastroenterol Nutr 2008;46:147-58
   PubMed Web of Science ®Google Scholar
• Fine J-D, Johnson LB, Weiner M, Suchindran C. Tracheolaryngeal complications of inherited epidermolysis bullosa. Laryngoscope 2007;117:1652-60
   PubMed Web of Science ®Google Scholar
• Fine J-D, Johnson LB, Weiner M, Inherited epidermolysis bullosa (EB) and the risk of death from renal disease: experience of the National EB Registry. Am J Kidney Dis 2004;44:651-60
   PubMed Web of Science ®Google Scholar
• Fine J-D, Johnson LB, Weiner M, Inherited epidermolysis bullosa (EB) and the risk of life-threatening skin-derived cancers: experience of the National EB Registry,1986-2006. J Am Acad Dermatol 2009;60:203-11
   PubMed Web of Science ®Google Scholar
• Fine J-D, Eady RAJ, Bauer JA, The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008;58:931-50
   PubMed Web of Science ®Google Scholar
• Gupta R, Woodley DT, Chen M. Epidermolysis bullosa acquisita. Clin Dermatol 2012;30:60-9
   PubMed Web of Science ®Google Scholar
• Pope E, Lara-Caralles I, Mellerio J, A consensus approach to wound care in epidermolysis bullosa. J Am Acad Dermatol 2012;67:904-17
   PubMed Web of Science ®Google Scholar
• Denyer JE. Wound management for children with epidermolysis bullosa. Dermatol Clin 2010;28:257-64
   PubMed Web of Science ®Google Scholar
• Schober-Flores C. Epidermolysis bullosa: the challenges of wound care. Dermatol Nurs 2003;15:135-44
   Google Scholar
• Goldschneider KR, Lucky AW. Pain management in epidermolysis bullosa. Dermatol Clin 2010;28:273-82
   PubMed Web of Science ®Google Scholar
• Arbuckle HA. Bathing for individuals with epidermolysis bullosa. Dermatol Clin 2010;28:265-6
   Google Scholar
• Haynes L. Nutritional support for children with epidermolysis bullosa. In: Fine JD, Hintner H, editors. Life with epidermolysis bullosa: etiology, diagnosis, and multidisciplinary care and therapy. Springer Verlag GmbH, Wien New York; 2009. p. 258-77
   Google Scholar
• Fine JD, Tamura T, Johnson L. Blood vitamin and trace metal levels in epidermolysis bullosa. Arch Dermatol 1989;125:374-9
   Google Scholar
• Ingen-Housz-Oro S, Blanchet-Bardon C, Vrillat M, Dubertrett L. Vitamin and trace levels in recessive dystrophic epidermolysis bullosa. J Eur Acad Dermatol Venereol 2004;18:649-53
   Google Scholar
• Reyes ML, Cattani A, Gajardo H. Bone metabolism in children with epidermolysis bullosa. J Pediatr 2002;140:467-9
   Google Scholar
• Fewtrell MS, Allgrove J, Gordon I, Bone mineralization in children with epidermolysis bullosa. Br J Dermatol 2006;154:959-62
   Google Scholar
• Chopra V, Tyring SK, Johnson L, Fine JD. Patients with severe forms of inherited epidermolysis bullosa exhibit decreased lymphokine and monokine production. J Clin Immunol 1990;10:321-9
   Google Scholar
• Wright JT, Fine J-D, Johnson L. Dental caries risk factors in hereditary epidermolysis bullosa. Pediatr Dent 1994;16:427-32
   PubMedGoogle Scholar
• Wright JT, Fine JD, Johnson LB. Oral soft tissues in hereditary epidermolysis bullosa. Oral Surg Oral Med Oral Pathol 1991;71:440-6
   PubMedGoogle Scholar
• Wright JT. Oral manifestations of epidermolysis bullosa. In: Fine JD, Bauer EA, McGuire J, Moshell A, editors. Epidermolysis bullosa. Clinical, epidemiologic, and laboratory advances and the findings of the National Epidermolysis Bullosa Registry. The Johns Hopkins University Press, Baltimore; 1999. p. 236-56
   Google Scholar
• Mellerio JE. Infection and colonization in EB. Dermatol Clin 2010;28:267-9
   Google Scholar
• Kingsley A. The wound infection continuum and its application to clinical practice. Ostomy Wound Manage 2003;49:1-7
   Google Scholar
• Murat-Susic S, Husar K, Skerley M, Inherited epidermolysis bullosa – the spectrum of complications. Acta Dermatolvenereol Croat 2011;19:255-63
   Google Scholar
• Browning JC, Levy ML. Argyria attributed to silvadene application in a patient with dystrophic epidermolysis bullosa. Dermatol Online J 2008;14:9
   Google Scholar
• Flohr C, Heague J, Leach I, English J. Topical silver sulfadiazine-induced systemic argyria in a patient with severe generalized epidermolysis bullosa. Br J Dermatol 2008;159:740-1
   Google Scholar
• Hon J. Using honey to heal a chronic wound in a patient with epidermolysis bullosa. Br J Nurs 2005;14:S4-12
   Google Scholar
• Molan PC. The evidence supporting the use of honey as a wound dressing. Int J Low Extrem Wounds 2006;5:40-54
   PubMedGoogle Scholar
• Al-Waili NS, Salom K, Butler G, Al Ghamdi AA. Honey and microbial infections: a review supporting the use of honey for microbial control. J Med Food 2011;14:1079-96
   PubMed Web of Science ®Google Scholar
• Fine J-D, Johnson LB, Weiner M, Eye involvement in inherited epidermolysis bullosa (EB): experience of the National EB Registry. Am J Ophthalmol 2004;138:254-62
   PubMed Web of Science ®Google Scholar
• Freeman E, Koglmeier J, Martinez AE, Gastrointestinal complications of epidermolysis bullosa in children. Br J Dermatol 2008;158:1308-14
   PubMed Web of Science ®Google Scholar
• Okada T, Sasaki F, Shimizu H, Effective esophageal balloon dilatation for esophageal stenosis due to epidermolysis bullosa. Eur J Pediatr Surg 2006;16:115-19
   Google Scholar
• Rosseneu S, Afzal N, Yerushalmi B, Topical application of mitomycin-C in oesophageal strictures. J Ped Gastroenterol Nutr 2007;44:336-41
   PubMed Web of Science ®Google Scholar
• Fine J-D, Johnson LB, Weiner M, Genitourinary complications of inherited epidermolysis bullosa (EB): experience of the National EB Registry and review of the literature. J Urol 2004;172:2040-4
   PubMed Web of Science ®Google Scholar
• Ida JB, Livshitz I, Azizkhan RG, Upper airway complications of junctional epidermolysis bullosa. J Pediatr 2012;160:657-61
   Google Scholar
• Fine J-D, Johnson LB, Weiner M, Pseudosyndactyly and musculoskeletal deformities in inherited epidermolysis bullosa (EB): experience of the National EB Registry, 1986-2002. J Hand Sur (British and European Volume) 2005;30B:14-22
   Google Scholar
• Smith FJ, Eady RAJ, Leigh IM, Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nature Genet 1996;13:450-7
   PubMed Web of Science ®Google Scholar
• Uitto J, Pulkkinen L, Smith FJD, McLean WHI. Plectin and human genetic disorders of the skin and muscle. Exp Dermatol 1996;5:237-46
   PubMedGoogle Scholar
• McMillan JR, Akiyama M, Rouan F, Plectin defects in epidermolysis bullosa simplex with muscular dystrophy. Muscle Nerve 2007;35:24-35
   Google Scholar
• Natsuga K, Nishie W, Akiyama M, Plectin expression patterns determine two distinct subtypes of epidermolysis bullosa simplex. Hum Mutat 2010;31:308-16
   Google Scholar
• Shivaswamy KN, Sumathy TK, Shyamprasad AL, Ranganathan C. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl. Int J Dermatol 2009;48:731-3
   PubMed Web of Science ®Google Scholar
• Tyring SK, Chopra V, Johnson L, Fine JD. Natural killer cell activity is reduced in patients with severe forms of inherited epidermolysis bullosa. Arch Dermatol 1989;125:797-800
   PubMedGoogle Scholar
• Arbiser JL, Fan CY, Su X, Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma. J Invest Dermatol 2004;123:788-90
   Google Scholar
• Ortiz-Urda S, Garcia J, Green CL, Type VII collagen is required for Ras-driven human epidermal tumorigenesis. Science 2005;307:1773-6
   Google Scholar
• Pourreyron C, Cox G, Mao X, Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression. J Invest Dermatol 2007;127:2438-44
   Google Scholar
• Venugopal SS, Murrell D. Treatment of skin cancers in epidermolysis bullosa. Dermatol Clin 2010;28:283-7
   Google Scholar
• Fine JD. Possible role of sentinal node biopsy in the management of squamous cell carcinomas in inherited epidermolysis bullosa. Arch Dermatol 2004;140:1012-13
   PubMedGoogle Scholar
• Rokunohe A, Nakano H, Aizu T, Significance of sentinel node biopsy in the management of squamous cell carcinoma arising from recessive dystrophic epidermolysis bullosa. J Dermatol 2008;35:336-40
   PubMed Web of Science ®Google Scholar
• Maubec E, Petrow P, Scheer-Senyarich I, Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin. J Clin Oncol 2011;29:3419-26
   PubMed Web of Science ®Google Scholar
• Azizkhan RG, Denyer JE, Mellerio JE, Surgical management of epidermolysis bullosa: Proceedings of the IInd International Symposium on Epidermolysis Bullosa, Santiago, Chile, 2005. Int J Dermatol 2007;46:801-8
   PubMed Web of Science ®Google Scholar
• Fine J-D, Johnson LB, Weiner M, Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretrinoin. J Am Acad Dermatol 2004;50:563-71
   PubMed Web of Science ®Google Scholar
• Souza CS, Felicio LB, Bentley MV, Topical photodynamic therapy for Bowen's disease of the digit in epidermolysis bullosa. Br J Dermatol 2005;153:672-4
   PubMed Web of Science ®Google Scholar
• Lanschuetzer CM, Emberger M, Hametner R, Pathogenic mechanisms in epidermolysis bullosa naevi. Acta Derm Venereol 2003;83:322-37
   Google Scholar
• Lanschuetzer CM, Emberger M, Laimer M, Epidermolysis bullosa naevi reveal a distinctive dermoscopic pattern. Br J Dermatol 2005;153:97-102
   Google Scholar
• Fine J-D, Hall M, Weiner M, The risk of cardiomyopathy in inherited epidermolysis bullosa. Br J Dermatol 2008;159:677-82
   PubMed Web of Science ®Google Scholar
• Lara-Corrales I, Mellerio JE, Martinez AE, Dilated cardiomyopathy in epidermolysis bullosa: a retrospective, multicenter study. Ped Dermatol 2010;27:238-43
   Google Scholar
• Wright JT, Fine JD, Johnson LB. Oral soft tissues in hereditary epidermolysis bullosa. Oral Surg Oral Med Oral Pathol 1991;71:440-6
   PubMedGoogle Scholar
• Wright JT, Johnson LB, Fine J-D. Developmental defects of enamel in humans with hereditary epidermolysis bullosa. Arch Oral Biol 1993;38:945-55
   PubMed Web of Science ®Google Scholar
• Wright JT, Hall KI, Deaton TG, Fine J-D. Structural and compositional alteration of tooth enamel in hereditary epidermolysis bullosa. Conn Tis Res 1996;34:271-9
   PubMedGoogle Scholar
• Wright JT. Hereditary defects of enamel. In: Robinson C, Kirkham J, Shore R, editors. Dental enamel formation to destruction. CRC Press, Boca Raton; 1995. p. 193-222
   Google Scholar
• Fine JD. Psychological and sociological aspects. In: Fine JD, Hintner H, editors. Life with Epidermolysis Bullosa (EB): etiology, diagnosis, multidisciplinary care and therapy. Springer, New York; 2008. p. 204-8
   Google Scholar
• Dures E, Morris M, Gleeson K, Rumsey N. The psychosocial impact of epidermolysis bullosa. Qual Health Res 2011;21:771-82
   PubMed Web of Science ®Google Scholar
• Magin P. Appearance-related bullying and skin disorders. Clin Dermatol 2013;31:66-71
   Google Scholar
• Fine J-D, Johnson LB, Weiner M, Suchindran C. Impact of inherited epidermolysis bullosa on parental interpersonal relationships, marital status, and family size. Br J Dermatol 2005;152:1009-14
   PubMed Web of Science ®Google Scholar
• WHOQOL Group. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995;41:1403-9
   PubMed Web of Science ®Google Scholar
• Sebaratnam DF, Frew JW, Davatchi F, Murrell DF. Quality-of-life measurement in blistering diseases. Dermatol Clin 2012;30:301-7
   Google Scholar
• Frew JW, Martin LK, Nijsten T, Murrell DF. Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument. Br J Dermatol 2009;161:1323-30
   PubMed Web of Science ®Google Scholar
• Jonkman MF, Scheffer H, Stulp R, Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell 1997;88:543-51
   PubMed Web of Science ®Google Scholar
• Lai-Cheong JE, McGrath JA, Uitto J. Revertant mosaicism in skin: natural gene therapy. Trends Mol Med 2011;17:140-8
   PubMed Web of Science ®Google Scholar
• Jonkman MF, Pasmooij AM. Revertant mosaicism--patchwork in the skin. N Engl J Med 2009;360:1680-2
   Google Scholar
• Jonkman MF, Castellanos Nuijts M, van Essen AJ. Natural repair mechanisms in correcting pathogenic mutations in inherited skin disorders. Exp Dermatol 2003;28:625-31
   Google Scholar
• Lai-Cheong J, Moss C, Parsons M, Revertant mosaicism in Kindler syndrome. J Invest Dermatol 2012;132:730-2
   Google Scholar
• Kalb R, Nevelng K, Hoehn H, Hypomorphic mutations in the gene encoding key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. Am J Hum Genet 2007;80:895-910
   PubMed Web of Science ®Google Scholar
• Stewart DM, Candotti F, Nelson DL. The phenomenon of spontaneous genetic reversions in the Wiskott-Aldrich syndrome: a report of the workshop of the ESID Genetics Working Party at the XIIth meeting of the European Society for Immunodeficiencies (ESID), Budapest, Hungary, October 4-7, 2006. J Clin Immunol 2007;27:634-9
   Google Scholar
• Gostynski A, Deviaene FC, Pasmooij AM, Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy. Br J Dermatol 2009;161:444-7
   PubMed Web of Science ®Google Scholar
• Laimer M, Bauer JW. Molecular therapy of epidermolysis bullosa. In: Fine JD, Hintner H, editors. Life with epidermolysis bullosa (EB): etiology, diagnosis, multidisciplinary care and therapy. Springer, New York; 2009. p. 287-308
   Google Scholar
• Mavilio F, Pellegrini G, Ferrari S, Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 2006;12:1397-402
   PubMed Web of Science ®Google Scholar
• Uitto J, McGrath JA, Rodeck U, Progress in epidermolysis bullosa research: toward treatment and cure. J Invest Dermatol 2010;130:1778-84
   Google Scholar
• Remington J, Wang X, Hou Y, Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. Mol Ther 2009;17:26-33
   PubMed Web of Science ®Google Scholar
• Heinonen S, Manniko M, Klement JF, Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa. J Cell Sci 1999;112:3614-48
   Google Scholar
• Woodley DT, Chen M. Fibroblasts as target cells for DEB gene therapy. J Invest Dermatol 2006;126:708-10
   Google Scholar
• Kern JS, Loeckermann S, Fritsch A, Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity. Mol Ther 2009;17:1605-15
   PubMed Web of Science ®Google Scholar
• Woodley DT, Krueger GG, Jorgensen CM, Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone. J Invest Dermatol 2003;121:1021-8
   PubMed Web of Science ®Google Scholar
• Wong T, Gammon L, Liu L, Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2008;128:2179-89
   PubMed Web of Science ®Google Scholar
• Uitto J. Molecular therapeutics for heritable skin diseases. J Invest Dermatol 2012;132
   Google Scholar
• Uitto J, Has C, Bruckner-Tuderman L. Cell-based therapies for epidermolysis bullosa - from bench to bedside. J Dtsch Dermatol Ges 2012;10:803-7
   PubMed Web of Science ®Google Scholar
• Nagy N, Almaani N, Tanaka A, HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2011;131:1771-4
   PubMed Web of Science ®Google Scholar
• Yan WF, Venugopal SS, Frew JW, Investigation of cell therapy for generalized severe recessive dystrophic epidermolysis bullosa by intradermal allogeneic fibroblasts randomized against placebo injections. J Invest Dermatol 2009;129:S28
   Google Scholar
• Yan WF, Murrell DF. Fibroblast-based cell therapy for recessive dystrophic epidermolysis bullosa. Dermatol Clin 2010;28:367-70
   Google Scholar
• Chino T, Tamai K, Yamazaki T, Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance. Am J Pathol 2008;173:803-14
   PubMed Web of Science ®Google Scholar
• Tolar J, McGrath JA, Keene DR, Hematopoietic and mesenchymal cell transplantation after myeloablative and non-myeloablative conditioning for recessive dystrophic and junctional epidermolysis bullosa (RDEB, JEB). J Invest Dermatol 2012;132:S91
   Google Scholar
• Kiuru M, Itoh M, Cairo MS, Christiano AM. Bone marrow stem cell therapy for recessive dystrophic epidermolysis bullosa. Dermatol Clin 2010;28:371-82
   PubMed Web of Science ®Google Scholar
• Wagner JE, Ishida-Yamamoto A, McGrath JA, Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 2010;363:629-39
   PubMed Web of Science ®Google Scholar
• Christiano AM, McGrath JA, Hillman E. Reduced intensity conditioning and allogeneic stem cell transplantation in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2009;129:S56
   Google Scholar
• Satwani P, Morris E, Bradley MB, Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases. Pediatr Blood Cancer 2008;50:1-8
   PubMedGoogle Scholar
• Tolar J, Xia L, Riddle MJ, Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2001;131:848-56
   Google Scholar
• Salas-Alanis JC, Cepeda-Valdes R, Mellerio JE, Progress in epidermolysis bullosa: summary of a workshop in CILAD-2010. Int J Dermatol 2012;51:682-7
   PubMedGoogle Scholar
• Uitto J, Christiano AM, McLean WH, McGrath JA. Novel molecular therapies for heritable skin disorders. J Invest Dermatol 2012;132:820-8
   Google Scholar
• Conget P, Rodriguez F, Kramer S, Replenishment of type VII collagen and reepithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy 2010;12:429-31
   PubMed Web of Science ®Google Scholar
• Kerem E, Hirawat S, Armoni S, Effectiveness of PT124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet 2008;372:719-27
   PubMed Web of Science ®Google Scholar
• Goldmann T, Overlack N, Wolfrum U, Nagel-Wolfrum K. PTC124-mediated translational readthrough of a nonsense mutation causing Usher syndrome IC. Hum Gene Ther 2011;22:537-47
   PubMed Web of Science ®Google Scholar
• Kopecki Z, Cowin AJ. Flightless I: an actin-remodelling protein and an important negative regulator of wound repair. Int J Biochem Cell Biol 2008;40:1415-19
   Google Scholar
• Kopecki Z, Arkell R, Powell BC, Cowin AJ. Flightless I regulates hemidesmosome formation and integrin-mediated cellular adhesion and migration during wound repair. J Invest Dermatol 2009;129:2031-45
   PubMed Web of Science ®Google Scholar
• Kopecki Z, Arkell RM, Strudwick XL, Overexpression of the Flii gene increases dermo-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisita. J Pathol 2011;225:401-13
   PubMed Web of Science ®Google Scholar
• Kopecki A, Ruzehaji N, Turner C, Topically applied flightless neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita. J Invest Dermatol 2012; published online 6 Dec 2012; doi:10/1038/id.2012.457
   Google Scholar
• Fine J-D. Epidermolysis bullosa: a genetic disease of altered cell adhesion and wound healing, and the possible clinical utility of topically applied thymosin b4. Ann NY Acad Sci 2007;1112:396-406
   PubMed Web of Science ®Google Scholar